IntelliQuit, a leader in tobacco treatment products & services, announced today the release of their first mobile app.
ALTRIA: More than Half of U.S. Population Now Governed by State Laws Raising Minimum Age of Purchase for All Tobacco Products to 21
Altria calls for 21 to be the nationwide standard
U.S. FDA: Launches its first youth e-cigarette prevention TV ads, plans new educational resources as agency approaches one-year anniversary of public education campaign
“The Real Cost” Youth E-Cigarette Prevention Campaign aims to reach nearly 10.7 million at-risk youth through TV, digital platforms, social media, in-school ads and posters nationwide
Opens Nu-X Headquarters in Southern California
22ND CENTURY GROUP, INC.: FDA Accepts and Files 22nd Century Group’s Modified Risk Tobacco Product Application for VLN™ Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, announced that the U.S. Food and Drug Administration (FDA) accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco Product (MRTP) application for its exclusive Very Low Nicotine Content (VLNC) cigarettes under the proposed brand name of VLNTM. 22nd Century’s proposed VLNTM cigarettes are made with the Company’s proprietary VLNC tobacco and, as a result, contain very low levels of nicotine.